According to Zhitong Finance App News, Kanghua Biotech (300841.SZ) announced that the shareholder Ningbo Shengdao Venture Capital Partnership (Limited Partnership) (hereinafter referred to as “Ningbo Shengdao”) and its co-operator Zibo Tiger Yingke Venture Capital Center (limited partnership) (hereinafter referred to as “Zibo Tiger”) plan to reduce the company's shares by no more than 3.165,800 shares (that is, no more than 2.4362% of the total share capital after excluding the repurchase of shares in the company's special account) within 3 months after the disclosure of this announcement.

Zhitongcaijing · 6d ago
According to Zhitong Finance App News, Kanghua Biotech (300841.SZ) announced that the shareholder Ningbo Shengdao Venture Capital Partnership (Limited Partnership) (hereinafter referred to as “Ningbo Shengdao”) and its co-operator Zibo Tiger Yingke Venture Capital Center (limited partnership) (hereinafter referred to as “Zibo Tiger”) plan to reduce the company's shares by no more than 3.165,800 shares (that is, no more than 2.4362% of the total share capital after excluding the repurchase of shares in the company's special account) within 3 months after the disclosure of this announcement.